DERCOS DS DANDRUFF TREATMENT OBSERVATIONAL STUDY 2022

N/ACompletedNCT05989633

Cosmetique Active International5,131 enrolled

Overview

The aim of this study is to evaluate the satisfaction / tolerance / cosmeticity of Dercos DS

Study Type

OBSERVATIONAL

Enrollment

5,131

Conditions

Dandruff

Interventions

Dermocosmetic product: Selenium Disluphide Shampoo (Dercos DS)OTHER

to assess the benefit of Dercos DS in subjects with dandruff

Eligibility

Sex: ALLMin age: 12 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with dandruff or seborrheic dermatitis * All hair types * All ethnicities (Asian, Caucasian, Afro-American, African, Hispanic) * Including patients with specific occlusion habits (for instance veil use at least 8 hours per day, hat use) * Patients willing to provide written informed consent Exclusion Criteria: * Under 12 years old * Pregnancy, breast feeding, childbearing potential without adequate contraception, or irregular menstrual cycles. * History of allergy, anaphylaxis or hypersensitivity to any of the ingredients of Shampoo any of the ingredients of DERCOS ANTI-DANDRUFF normal to oily hair shampoo * History of allergic contact dermatitis secondary to shampoo, conditioner, mask, and/or leave-in. * Has any clinical manifestations in the treatment(s) or other disorders that, in the opinion of the investigator, may affect the evaluations or results of the study products.- Inability to stay the study period (56 days +-5 days) without performing any hair/scalp procedure, including coloring, straightening and cutting. * Inability to attend all study visits and follow treatment regimen

Locations (1)

Marta Sar Pormian

Warsaw, Poland